Liege, Belgium – 11 April 2025 (17:00 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, […]
Liege, Belgium – 25 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, […]
Liege, Belgium – 4 March 2025 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology-based treatment for degenerative joint […]
Liège 17 February 2025 – Allegro, a pioneering biomedical company from Belgium, has won the prestigious Companion Animals Prize for its hydrocelin […]
Allegro is Heading to the Biotech Showcase in San Francisco! We’re excited to announce that Allegro will be attending the Biotech Showcase […]
Liege, Belgium – 11 December 2024 (07:30 CET) – Allegro NV, a biomedical companydeveloping transformative nanotechnology-based devices for degenerative joint disease, todayannounced […]
We are thrilled to announce that Allegro has won 3rd prize at the prestigious HealthTech Innovation Days (HTID) event in Paris! The […]
Read the interview with our CSO and co-founder Jorg Schelfhout in ‘De Tijd’. https://www.tijd.be/ondernemen/farma-biotech/jong-geweld-jorg-schelfhout-allegro-werken-in-een-vast-kader-sneed-me-de-adem-af/10557860.html
Allegro is honored to receive the esteemed China (Zhejiang) European Life Sciences Innovation Fund (ZELSIF) Award. This accolade, given to the most […]
We’ll be participating at the upcoming anniversary edition of “Knowledge 4 Growth” in Antwerp, upcoming May 15-16th. Knowledge for Growth is at […]